Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells

Ribosomal DNA as DAMPs Signal for MCF7 Cancer Cells

Introduction: The cell free ribosomal DNA (cf-rDNA) is accrued in the total pool of cell free DNA (cfDNA) in some non-cancer diseases and demonstrates DAMPs characteristics. The major research questions: (1) How does cell free rDNA content change in breast cancer; (2) What type of response in the MC...

Full description

Bibliographic Details
Main Authors:	Elena M. Malinovskaya, Elizaveta S. Ershova, Natalya A. Okorokova, Vladimir P. Veiko, Marina S. Konkova, Ekaterina A. Kozhina, Ekaterina A. Savinova, Lev N. Porokhovnik, Serguey I. Kutsev, Nataly N. Veiko, Svetlana V. Kostyuk
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-05-01
Series:	Frontiers in Oncology
Subjects:	DAMPs human ribosomal gene rDNA TLR9 AIM2 cfDNA
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2019.00445/full

Similar Items

Copy Number of Human Ribosomal Genes With Aging: Unchanged Mean, but Narrowed Range and Decreased Variance in Elderly Group
by: Elena M. Malinovskaya, et al.
Published: (2018-08-01)

Mild cognitive impairment is associated with low copy number of ribosomal genes in the genomes of elderly people
by: Natalia N. Veiko, et al.
Published: (2022-09-01)

Graft-Derived Cell-Free DNA Quantification following Liver Transplantation Using Tissue-Specific DNA Methylation and Donor-Specific Genotyping Techniques: An Orthogonal Comparison Study
by: Daniel R. A. Cox, et al.
Published: (2023-06-01)

Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
by: Morten Lapin, et al.
Published: (2018-11-01)

A new primer construction technique that effectively increases amplification of rare mutant templates in samples
by: Jr-Kai Huang, et al.
Published: (2019-08-01)

Donor-Derived Cell-Free DNA in Kidney Transplantation as a Potential Rejection Biomarker: A Systematic Literature Review
by: Adrian Martuszewski, et al.
Published: (2021-01-01)

1Q12 Loci Movement in the Interphase Nucleus Under the Action of ROS Is an Important Component of the Mechanism That Determines Copy Number Variation of Satellite III (1q12) in Health and Schizophrenia
by: Marina Sergeevna Konkova, et al.
Published: (2020-06-01)

Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
by: Jonathan Dao, et al.
Published: (2023-08-01)

Evaluation of commercial kits for isolation and bisulfite conversion of circulating cell-free tumor DNA from blood
by: Stine H. Kresse, et al.
Published: (2023-09-01)

Deep cfDNA fragment end profiling enables cancer detection
by: Yulia V. Zhitnyuk, et al.
Published: (2022-01-01)

Circulating cell-free DNA as a biomarker for diagnosis of Schistosomiasis japonica
by: Yu Zhang, et al.
Published: (2024-03-01)

The cfDNA in early cancer detection
by: Hussein Adil Abid, et al.
Published: (2024-01-01)

Circulating Cell-Free DNA as a Prognostic Biomarker in Resectable Ampullary Cancer
by: Bor-Uei Shyr, et al.
Published: (2021-05-01)

Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer
by: Bram De Laere, et al.
Published: (2021-03-01)

Fluorometric Quantification of Total Cell-Free DNA as a Prognostic Biomarker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Blockade
by: Javier Oliver, et al.
Published: (2023-06-01)

BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings
by: Pancrazzi Pancrazzi, et al.
Published: (2023-09-01)

Targeted fetal cell‐free DNA screening for aneuploidies in 4,594 pregnancies: Single center study
by: Altug Koc, et al.
Published: (2019-07-01)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
by: Maxim Ivanov, et al.
Published: (2019-03-01)

In Vitro Analysis of Biological Activity of Circulating Cell-Free DNA Isolated from Blood Plasma of Schizophrenic Patients and Healthy Controls
by: Elizaveta S. Ershova, et al.
Published: (2022-03-01)

Putative Origins of Cell-Free DNA in Humans: A Review of Active and Passive Nucleic Acid Release Mechanisms
by: Stefan Grabuschnig, et al.
Published: (2020-10-01)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
by: Emma Sandberg, et al.
Published: (2024-01-01)

Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions
by: Kuo-Ping Chiu, et al.
Published: (2019-08-01)

Neutrophil extracellular traps in stored canine red blood cell units
by: Erin R. McQuinn, et al.
Published: (2020-09-01)

<i>ANK2</i> Hypermethylation in Canine Mammary Tumors and Human Breast Cancer
by: Johannes J. Schabort, et al.
Published: (2020-11-01)

Liquid Biopsy &ndash; Possibilities for Monitoring&nbsp;the Therapeutic Response in Non-Small Cell Lung Cancer
by: Gabriela A. Raycheva, et al.
Published: (2021-12-01)

Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas
by: Ramón Diez-Feijóo, et al.
Published: (2024-01-01)

Biguanide chitosan microneedles with cell-free DNA scavenging ability for psoriasis therapy
by: Zihao Liu, et al.
Published: (2024-03-01)

Ultra Deep Sequencing of Circulating Cell-Free DNA as a Potential Tool for Hepatocellular Carcinoma Management
by: Mónica Higuera, et al.
Published: (2022-08-01)

Comparing cell‐free circulating tumor DNA mutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
by: Alok R. Khandelwal, et al.
Published: (2020-10-01)

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
by: Vinh Thanh Tran, et al.
Published: (2020-08-01)

A Noninvasive Multianalytical Approach for Lung Cancer Diagnosis of Patients with Pulmonary Nodules
by: Quan‐Xing Liu, et al.
Published: (2021-07-01)

Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC?
by: Yi-Ze Li, et al.
Published: (2023-02-01)

Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis
by: Mark M. Melamud, et al.
Published: (2023-02-01)

International pilot external quality assessment scheme for analysis and reporting of circulating tumour DNA
by: Cleo Keppens, et al.
Published: (2018-08-01)

Clinical Validity of Circulating Tumor DNA as Prognostic and Predictive Marker for Personalized Colorectal Cancer Patient Management
by: Ariane Hallermayr, et al.
Published: (2022-02-01)

The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
by: Ian A. Cree, et al.
Published: (2017-10-01)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
by: Dilys Lam, et al.
Published: (2020-10-01)

Extracellular Vesicle-Derived DNA vs. CfDNA as a Biomarker for the Detection of Colon Cancer
by: Kavita Thakur, et al.
Published: (2021-07-01)

The Psychoemotional Stress-Induced Changes in the Abundance of SatIII (1q12) and Telomere Repeats, but Not Ribosomal DNA, in Human Leukocytes
by: Pavel E. Umriukhin, et al.
Published: (2022-02-01)

A Fully Integrated Microfluidic Device with Immobilized Dyes for Simultaneous Detection of Cell-Free DNA and Histones from Plasma Using Dehydrated Agarose Gates
by: Shadi Shahriari, et al.
Published: (2024-03-01)